Genetically Engineered Hepatitis B Vaccine is a recombinant yeast culture expressed HbsAg purified, inactivated and adsorbed with adjuvant for the prevention of Hepatitis B. It contains no blood components. It does not contain any blood components.

Target:

1, newborns, children and, primary and secondary school students.

2, health care workers, child care workers, blood donors and adults who are exposed to hepatitis B virus due to their occupation.

3, education, medicine, food, transportation, commerce, banking, catering, tourism, service and other industries.

4, military, armed police and public security personnel.

5, newlyweds, travelers and people in areas with high prevalence of hepatitis B.

Methods and dosage:

Injection site of the upper arm within the triangular muscle, the vaccination program for 0, 1, 6 months, that is, the second needle and the first needle one month apart, the third needle and the second needle five months apart, the whole process of **** three injections, completed in six months.

Contraindications:

1, Persons suffering from hepatitis, acute infections or other serious diseases. 2, Those who are allergic to yeast or any component of the vaccine.